Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Legoux

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 25, 2011
Hepato-gastroenterologists and oncologists are complementary in the management of digestive cancersPhilippe Rougier, Jean-Louis Legoux, Côme Lepage, et al.
Gastroenterologie Clinique Et Biologique|December 8, 2006
Rectal cancerJean-Louis Legoux, Paul-Antoine Lehur, Christophe Penna, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2010
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinomaFranck Bonnetain, Laetitia Dahan, Emilie Maillard, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 10, 2017
Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)Jean-Pierre Gérard, Thierry André, Frédéric Bibeau, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapyXavier Adhoute, Denis Smith, Véronique Vendrely, et al.
Anticancer Research|November 11, 2006
Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial)Jacqueline Duffour, Olivier Bouché, Philippe Rougier, et al.
Clinics and Research in Hepatology and Gastroenterology|September 13, 2011
Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: a first-line phase II studyMarianne Fonck, Réné Brunet, Yves Becouarn, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 14, 2015
FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802)Thomas Aparicio, Benjamin Linot, Karine Le Malicot, et al.
Neuroendocrinology|February 14, 2019
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score AnalysesLouis de Mestier, Thomas Walter, Hedia Brixi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2021
Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trialsClémence Breton, Thomas Aparicio, Karine Le Malicot, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 25, 2011
Hepato-gastroenterologists and oncologists are complementary in the management of digestive cancersPhilippe Rougier, Jean-Louis Legoux, Côme Lepage, et al.
Gastroenterologie Clinique Et Biologique|December 8, 2006
Rectal cancerJean-Louis Legoux, Paul-Antoine Lehur, Christophe Penna, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2010
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinomaFranck Bonnetain, Laetitia Dahan, Emilie Maillard, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 10, 2017
Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)Jean-Pierre Gérard, Thierry André, Frédéric Bibeau, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapyXavier Adhoute, Denis Smith, Véronique Vendrely, et al.
Anticancer Research|November 11, 2006
Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial)Jacqueline Duffour, Olivier Bouché, Philippe Rougier, et al.
Clinics and Research in Hepatology and Gastroenterology|September 13, 2011
Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: a first-line phase II studyMarianne Fonck, Réné Brunet, Yves Becouarn, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 14, 2015
FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802)Thomas Aparicio, Benjamin Linot, Karine Le Malicot, et al.
Neuroendocrinology|February 14, 2019
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score AnalysesLouis de Mestier, Thomas Walter, Hedia Brixi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2021
Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trialsClémence Breton, Thomas Aparicio, Karine Le Malicot, et al.
Pageof 4